
Journal of Medicinal Chemistry p. 4384 - 4392 (1992)
Update date:2022-08-02
Topics:
Harris, Neil V.
Smith, Christopher
Asthon, Michael J.
Bridge, Andrew W.
Bush, Raymond C.
et al.
A potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells.We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl moiety, inhibits rat hepatic microsomal ACAT in vitro and produces a significant hypocholesterolemic effect in the cholesterol-fed rat.Structure-activity relationships for analogues of 2 demonstrate that the 4,5-diphenyl-1H-imidazole moiety is a pharmacophore for inhibition of rat microsomal ACAT.
View MoreChangsha Yihai Chemical Technology Co.,ltd
website:http://www.cs-yihai.com/
Contact:0731- 85620465
Address:Room 23005, unit 2, the northern building of Xiangsong international building , NO.259 Shaoshan Road , Changsha , Hunan, China.(mainland)
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Contact:13357117572
Address:No.149 Shiji dadao Road.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
hangzhou sunchem trading co., ltd.
Contact:13588470430--
Address:Room 406-407, the 4th Building, No549
Doi:10.1007/BF00503478
(1981)Doi:10.1039/c39850000190
(1985)Doi:10.1021/je00042a047
(1985)Doi:10.1016/S0040-4039(00)98119-X
(1985)Doi:10.1021/jacs.5b07438
(2015)Doi:10.1021/jm00149a029
(1985)